Ligand Pharmaceuticals stock trades on Nasdaq; Bank of America provides coverage and rating reports; required 13F reports are filed with the SEC.

The entities involved

• Ligand Pharmaceuticals →

  biopharmaceutical company based out of La Jolla, California

  • Ligand Pharmaceuticals committed funding and royalty rights to AvenCell Therapeutics, Inc.Sun 17:54
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• Securities and Exchange Commission →

  government agency of the Philippines

  • BlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Mon 16:42
  • Filing required regarding institutional holdings for Schwab Emerging Markets Equity ETF and Waterford Advisors LLC with the SEC.Mon 16:38

Related events

• Vertex Pharmaceuticals had required 13F filings with the SEC and its stock traded on the Nasdaq exchange on September 8, 2026.Sep 9
• Cyclerion Therapeutics, Inc. filed reports with the SEC, and MarketBeat provided stock rating data.Jun 23
• United Therapeutics filed Form 13F with the Securities and Exchange Commission.Jun 18
• MarketBeat provides stock rating data for Vivos Therapeutics, which is listed on Nasdaq.Sep 15
• LiveRamp filed its required 13F reports with the Securities and Exchange Commission.Sep 9